|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016011,
umls-concept:C0023981,
umls-concept:C0034975,
umls-concept:C0087111,
umls-concept:C0184511,
umls-concept:C0205547,
umls-concept:C0233820,
umls-concept:C0332281,
umls-concept:C0522523,
umls-concept:C1274040,
umls-concept:C1522318,
umls-concept:C1524063,
umls-concept:C1948041,
umls-concept:C1999216
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-2-1
|
|
pubmed:abstractText |
Clinical trials have demonstrated the benefit of glycoprotein IIb/IIIa inhibitors (GPIs) with stenting in the setting of percutaneous coronary intervention (PCI) in reducing adverse cardiac outcomes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0828-282X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
27-32
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15685299-Aged,
pubmed-meshheading:15685299-Analysis of Variance,
pubmed-meshheading:15685299-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15685299-Clinical Trials as Topic,
pubmed-meshheading:15685299-Cohort Studies,
pubmed-meshheading:15685299-Combined Modality Therapy,
pubmed-meshheading:15685299-Confidence Intervals,
pubmed-meshheading:15685299-Coronary Angiography,
pubmed-meshheading:15685299-Coronary Disease,
pubmed-meshheading:15685299-Dose-Response Relationship, Drug,
pubmed-meshheading:15685299-Drug Administration Schedule,
pubmed-meshheading:15685299-Female,
pubmed-meshheading:15685299-Follow-Up Studies,
pubmed-meshheading:15685299-Hospital Mortality,
pubmed-meshheading:15685299-Humans,
pubmed-meshheading:15685299-Male,
pubmed-meshheading:15685299-Middle Aged,
pubmed-meshheading:15685299-Odds Ratio,
pubmed-meshheading:15685299-Ontario,
pubmed-meshheading:15685299-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15685299-Probability,
pubmed-meshheading:15685299-Prospective Studies,
pubmed-meshheading:15685299-Registries,
pubmed-meshheading:15685299-Severity of Illness Index,
pubmed-meshheading:15685299-Stents,
pubmed-meshheading:15685299-Survival Rate,
pubmed-meshheading:15685299-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry.
|
|
pubmed:affiliation |
University Health Network, Toronto, Ontario. Cynthia.Jackevicius@uhn.on.ca
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
